About Us

 

Primal Health was launched in 2017 to tackle the oral health crisis in humans and animals, mainly as the result of Dr. Emily Stein's love for her grandmother, who experienced a health crisis due to dental disease while in assisted living. After several tooth extractions, she suffered a major stroke which significantly impaired her mobility and quality of life. Witnessing the downward spiral of her grandmother’s health combined with her expertise in microbiology and immunology, created the perfect storm for innovation.

Since 2008, Dr. Stein has been working on the solution to the pervasive problem of dental disease. She patented her creation, Selective Microbial Metabolism Regulation Technology (SMMRT)™, which displays the unique capability of selectively manipulating oral microbes and their behaviors by simply using nutrient stress. The ability to selectively grow beneficial bacteria to out-compete the bad in any given environment results in far better outcomes than any current approaches in the market. 

READ MORE - BENZINGA - Oral Microbiome's Huge Impact on Systemic Wellbeing (interview with Dr. Emily Stein)

READ MORE - MARKETS INSIDER - Health Emergency Leads Dr Emily Stein to Create Microbiome-Focused Total Oral Health Solution

 

INVENTOR - EMILY STEIN, Ph.D.

Dr. Emily Stein is working to redefine the landscape of oral and systemic health. Her leadership is driving the development of cutting-edge microbiome modulatory products, while unraveling the intricacies of biofilm-related oral and systemic diseases.

She has founded five biotech start-ups, addressing challenges in fields including the sympathetic nervous system, infectious disease diagnostics, exosome biology and cancer diagnostics, pulmonary fibrosis, and periodontal disease. Her work has resulted in 18 issued patents.

Dr. Stein has 18 patents, has delivered over 23 professional lectures on the global stage and has earned numerous awards and accolades, making her a respected authority in the realm of oral microbiome and soft tissue inflammation.

Dr. Stein's journey of building lean start-ups and delivering transformative clinical outcomes has set a new standard for excellence. Her guiding principles include prioritizing patient needs and assembling a passionate, results-driven team. Her pursuit of innovative solutions has demonstrated that an omni-channel approach is the key to revolutionizing the healthcare industry.

She earned a B.A. in Anthropology at the University of Iowa, and a B.S. in Microbiology and Immunology. There, her work explored the interactions between M. tuberculosis and alveolar macrophages, laying the foundation for her future scientific endeavors.

Dr. Stein completed her Post-Doctoral Fellowship at Stanford University School of Medicine, in the Department of Immunology & Rheumatology. Her work yielded insights into the neuroendocrine-immune axis and its role in autoimmune diseases like rheumatoid arthritis. Her research uncovered the significance of endogenous cardiogenic steroids and led to the development of a small molecule approach to stimulate regulatory B cells - ultimately reducing autoantibody production. Her work has resulted in a cost-effective treatment for myasthenia gravis, making a profound impact in low-income countries.

She earned a Ph.D. in Microbiology at the UC, Berkeley. Her research, focused on serine/threonine and tyrosine kinase-dependent signaling pathways in bacteria and biofilm development, showcased her dedication to pushing the boundaries of scientific understanding.

The microbiome modulatory technology that she has developed hold promise in addressing an array of diseases that range from dental cavities and periodontal disease to cancer and diabetes. Dr. Stein’s technologies have the potential to revolutionize agriculture and clinical practices. Some of her technologies are currently being tested by the European Space Agency and NASA and have garnered the attention of high-level government agencies.

Dr. Emily Stein's relentless pursuit of excellence has and will continue to make a notable impact on the fields of science and healthcare.